@article{104140, keywords = {coronavirus disease, Hansen’s disease, Leprosy Disease, Leprosy reactions}, author = {Hammad RRM and Abdel-Alaeem HL and Khalaf-Allah SM}, title = {Leprosy disease and its reactions in the era of corona virus disease 2019}, abstract = {
Background
Coronavirus disease 2019 (COVID-19) is a serious worldwide health problem that affects direct and indirect however, the implications of COVID-19 co-infection in patients with Hansen’s disease remain uncertain this study aimed to assess the relationship between COVID-19 and leprosy and its reactions.
Patients and methods
This is a descriptive retrospective study conducted on 200 patients presented with different clinical forms of leprosy, according to COVID-19 infection, they divided into two groups, group I=98 COVID-19 positive patients and group II=102 COVID-19 negative patients.
Results
Significant decrease in COVID-19 co-infection among lepromatous leprosy patients with a significant decrease in leprosy reactions. Significant increase in COVID-19 co-infection among tuberculoid patients with a significant increase in leprosy reactions and in number of lepra bacilli detected by slit skin smear among COVID-19 negative patients ( P <0.05). No significant difference between the two groups as regards the classification of leprosy, mode of infection of leprosy, and grade of disability ( P >0.05).
Conclusion
COVID-19 co-infection may enhance leprosy reactions.
}, year = {2026}, journal = {Al-Azhar Assiut Medical Journal}, volume = {24}, pages = {435 - 439}, month = {09/2026}, publisher = {Ovid Technologies (Wolters Kluwer Health)}, issn = {1687-1693, 2536-9652}, url = {https://www.ovid.com/jnls/aamj/pdf/10.4103/azmj.azmj_50_23~leprosy-disease-and-its-reactions-in-the-era-of-corona-virus}, doi = {10.4103/azmj.azmj_50_23}, language = {ENG}, }